81 results
8-K
EX-99.2
e8udw non
8 Jan 24
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
8:30am
424B5
p8xjrs ypnd9
2 Nov 23
Prospectus supplement for primary offering
4:59pm
8-K
EX-99.1
ntyldtkg y5p3ixzx
13 Oct 23
Other Events
4:16pm
8-K
EX-10.1
eskvur
30 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
0ws q9171tbt7x
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-10.2
s3ajdtxm w1vxktbdxt4
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-4.1
pww2kd4dzcj4g bz
17 Apr 23
Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering
4:17pm
S-3ASR
EX-4.3
qwonr muvu8fz1h
9 Sep 22
Automatic shelf registration
4:31pm